Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latex sublingual immunotherapy versus placebo in adults with latex allergy
ACTRN12611000543987Phase 3Completed
- Sponsor
- Hospital Santiago Apóstol
- Start
- Feb 2004
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of latex sublingual immunotherapy in latex allergy (2 arms), sponsored by Hospital Santiago Apóstol. Primary endpoint: Skin prick test wheal size at 24 months. Started Feb 2004; status: completed.
02
Drugs
latex sublingual immunotherapy
03
Conditions
latex allergy
Beyond the preview
Go deeper on ACTRN12611000543987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000543987.